I like the following but IMO if all stays on track it will go much higher in the months ahead. "RFC Ambrian reiterated its A¢27.9 (15.3p) fair value estimate and ‘speculative buy’ rating on the stock" GL to all holders.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025